- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dissection, Thoracic Aorta in Korea, Republic of
Total 1051 results
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
AstraZenecaActive, not recruitingNon Small Cell Lung CancerBelgium, Korea, Republic of, Spain, United States, France
-
BayerTerminatedCarcinoma, Non-Small-Cell LungChina, Taiwan, Singapore, Thailand, Korea, Republic of, India
-
Novartis PharmaceuticalsRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Spain, Japan, Germany, Switzerland
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Taiwan, Italy, Korea, Republic of
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIKorea, Republic of, Poland, Spain, Turkey
-
AstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
-
Eli Lilly and CompanyCompletedSmall Cell Lung CancerUnited States, Korea, Republic of, Romania
-
Boehringer IngelheimCompletedAdenocarcinoma | Carcinoma, Non-Small-Cell LungChina, Korea, Republic of, Thailand
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSpain, Korea, Republic of, Turkey, France, United States
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
SanofiTerminatedBreast Cancer | Gastric Cancer | Neoplasm | Lung Neoplasm Malignant | Neoplasm MalignantBelgium, Korea, Republic of, United States, Taiwan, Spain, France
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungBelgium, Germany, United States, Canada, France, Italy, Japan, Korea, Republic of, Spain
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Taiwan, Korea, Republic of, Japan, Spain
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Hoffmann-La RocheCompletedSmall Cell Lung Carcinoma | Hepatocellular Carcinoma | Carcinoma, Non-Small Cell Lung | Urothelial Carcinoma | Triple Negative Breast CarcinomaKorea, Republic of
-
NewLink Genetics CorporationCompletedNon-Small Cell Lung CancerRussian Federation, Ukraine
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Spain, France, United Kingdom, Hong Kong
-
AstraZenecaCompletedCarcinoma, Non-small-cell LungUnited States, Canada, Korea, Republic of, United Kingdom, Czech Republic
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Hong Kong, Taiwan, Philippines, Thailand, Korea, Republic of, Indonesia
-
Impact Therapeutics, Inc.RecruitingSmall Cell Lung Cancer | Advanced Solid TumoursTaiwan, Korea, Republic of, China, Australia, United States
-
Genentech, Inc.RecruitingColorectal Cancer | Non-Small Cell Lung CancerKorea, Republic of, Australia, Canada, United States
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Daiichi Sankyo, Inc.CompletedAdvanced Non-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, India, Germany
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
Taiho Oncology, Inc.RecruitingNon-Small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Japan, Spain, Germany, Netherlands, United Kingdom
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerTaiwan, Korea, Republic of, Brazil, China, Australia, Mexico
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Colorectal Cancer | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal | Non-Small Cell Lung Carcinoma | KRAS G12C Mutant Solid TumorsKorea, Republic of, Spain, Belgium, United States, France, Germany, Italy, Singapore
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Eli Lilly and CompanyCompletedCarcinoma, Non Small Cell LungTaiwan, Japan, Korea, Republic of, China
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
Merck Sharp & Dohme LLCRecruitingNon Small Cell Lung CancerUnited States, Israel, Taiwan, Korea, Republic of, Switzerland, Hong Kong
-
National Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Bristol-Myers SquibbCompletedSmall Cell Lung CancerUnited States, Belgium, Canada, Puerto Rico, Australia, Korea, Republic of, Netherlands
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
Turning Point Therapeutics, Inc.TerminatedNon Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Medullary Thyroid Cancer | RET Gene MutationUnited States, Korea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
AVEO Pharmaceuticals, Inc.CompletedLung Neoplasms | Respiratory Tract Neoplasms | Lung Cancer | Carcinoma, Non-Small Cell-LungHong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungChina, Korea, Republic of, Singapore, Thailand, Malaysia
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Ukraine
-
Hoffmann-La RocheActive, not recruitingMetastatic Melanoma | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Esophageal Squamous Cell Carcinoma (ESCC) | Small Cell Lung Cancer (SCLC)United States, Korea, Republic of, Denmark, France, Spain, New Zealand
-
Regeneron PharmaceuticalsActive, not recruitingNSCLCUnited States, France, Korea, Republic of